Close Menu

White House

Around the Regions: May 1, 2009

Premium

California Institute for Regenerative Medicine, Vermont Pharma Marketing Disclosure Bills, New England Biotech Association, US Energy Frontier Research Centers, Donald Danforth Plant Science Center, New York Biotechnology Association, Pharmaceutical Research and Manufacturers of America, Idea Networks of Biomedical Research Excellence, Pittsburgh Entrepreneur Fund, Massachusetts Life Sciences Center Accelerator Program, Maryland Technology Development Corporation, San Diego Center for Algae Biotechnology

Obama said that the US is in danger of slipping from its lead spot in science innovation and called for "a historic investment" in research and education that would fuel innovation as the GI Bill did a half-century ago.

Industry stakeholders and patient advocates are urging the government to ensure that any resulting comparative effectiveness program not focus solely on reducing cost but on using pharmacogenomics to improve patient outcomes.

The omnibus budget to fill in the fiscal year now goes to President Obama with $30.3 billion for NIH.

The White House science policy office will draft a plan aimed at keeping science free from political meddling and distortion.

While kicking off an overhaul of healthcare, the 2010 budget also proposes doubling cancer funding and increasing NSF research funds.

In the wake of the stimulus boost, the omnibus bill kicks off 2009 funding talks as the 2010 process is about to get underway.

The final version of the $787 billion economic stimulus act contains $10 billion in funding for the National Institutes of Health, as well as billions of dollars of funding for other science funding agencies.

Funding from the National Institutes of Health for all proteomics-related research shrank by almost 3 percent in fiscal 2008, according to an analysis of NIH data by ProteoMonitor.

Pages

A new study catalogues the genome and evolutionary history of the oak family, UPI reports.

Dog DNA testing is a growing market, but there's still a lot of uncertainty about the accuracy of the results, the Boston Globe says.

A University of South Florida researcher is testing bone fragments to determine if they belong to Amelia Earhart.

In Cell this week: antisense Piwi-interacting RNA responses to endogenous retroviruses, proteomic patterns in hepatocellular carcinoma, and more.